ALLOGENE THERAPEUTICS

allogene-therapeutics-logo

Allogene Therapeutics is a clinical stage immuno-oncology company. It is mainly engaged in the development and commercialization of genetically engineered allogeneic T cell therapies for the treatment of cancer. The company is involved in developing a pipeline of multiple allogeneic T cell product candidates utilizing validated gene editing and advanced proprietary cell manufacturing technologies. Its pipeline includes UCART19 which is developed for the treatment of relapsed or refractory acute lymphoblastic leukemia (ALL), as well as several preclinical allogeneic CAR T therapies.

#SimilarOrganizations #People #Financial #Event #Website #More

ALLOGENE THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Diagnostics Pharmaceutical

Founded:
2017-01-01

Address:
South San Francisco, California, United States

Country:
United States

Website Url:
http://www.allogene.com

Total Employee:
101+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
531.77 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network


Similar Organizations

advanced-cell-diagnostics-logo

Advanced Cell Diagnostics

Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.

akouos-logo

Akouos

Akouos is a biotechnology company focusing on restoring and preserving hearing.

algotherapeutix-logo

AlgoTherapeutix

AlgoTherapeutix is the operator of a biotechnology company designed to develop topical treatments for complex pain.

aura-biosciences-logo

Aura Biosciences

Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.

centessa-pharmaceuticals-logo

Centessa Pharmaceuticals

Centessa Pharmaceuticals is a next-generation biopharmaceutical company that aims to reshape the traditional drug development process.

day-one-biopharmaceuticals-logo

Day One Biopharmaceuticals

Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.

genetx-biotherapeutics-logo

GeneTx Biotherapeutics

GeneTx Biotherapeutics is a biotechnology company that focuses on developing therapeutics for the treatment of Angelman syndrome.

glycologix-logo

Glycologix

Glycologix is a biotechnology company that specializes in R&D of biomaterials for the protection and repair of soft tissues.

graphite-bio-logo

Graphite Bio

Graphite Bio is a next-generation gene editing company that is driven to apply our breakthrough technology.

gro-biosciences-logo

GRO Biosciences

GRO Biosciences is a biotechnology company that expands the amino acid alphabet to overcome the limitations of protein therapeutics.

medeor-therapeutics-logo

Medeor Therapeutics

Medeor Therapeutics is a biotechnology company that dedicates to dedicates to the development of personalized cellular immunotherapies.

moderna-therapeutics-logo

Moderna Therapeutics

Moderna Therapeutics is a biotechnology company that specializes in drug discovery and drug development based on messenger RNA.

halo-labs-logo

Halo Labs

Halo Labs is a biotechnology company that specializes in analytical instrumentation and biopharma.

predxion-bio-logo

PreDxion Bio

PreDxion Bio is revolutionizing testing and treatment through low-cost, user-friendly at-home diagnostics.

selva-therapeutics-logo

Selva Therapeutics

Selva Therapeutics is a privately held biotechnology company dedicated to the development of therapeutics for infectious diseases.

shape-therapeutics-logo

Shape Therapeutics

A biotechnology company developing RNA technologies to shape the future of gene therapy

stalicla-logo

Stalicla

STALICLA is a Swiss biotechnology company developing precision medicine treatments for patients with Neurodevelopmental disorders


Current Advisors List

joshua-kazam_image

Joshua Kazam Board Member @ Allogene Therapeutics
Board_member
2017-11-01

arie-belldegrun_image

Arie Belldegrun Executive Chairman & Co-Founder @ Allogene Therapeutics
Board_member
2017-01-01

david-bonderman_image

David Bonderman Board Member @ Allogene Therapeutics
Board_member

franz-humer_image

Franz Humer Board Member @ Allogene Therapeutics
Board_member

deborah-messemer_image

Deborah Messemer Board Member @ Allogene Therapeutics
Board_member
2018-09-01

john-deyoung_image

John DeYoung Board Member @ Allogene Therapeutics
Board_member

owen-witte_image

Owen Witte Board Member @ Allogene Therapeutics
Board_member

todd-sisitsky_image

Todd Sisitsky Board Member @ Allogene Therapeutics
Board_member

Current Employees Featured

david-chang_image

David Chang
David Chang Chief Executive Officer and Co-Founder @ Allogene Therapeutics
Chief Executive Officer and Co-Founder

david-chang_image

David Chang
David Chang President, CEO and Co-Founder @ Allogene Therapeutics
President, CEO and Co-Founder

joshua-kazam_image

Joshua Kazam
Joshua Kazam Co-Founder @ Allogene Therapeutics
Co-Founder

robert-to_image

Robert To
Robert To Associate Director, External Testing Oversight @ Allogene Therapeutics
Associate Director, External Testing Oversight
2019-09-01

rafael-amado_image

Rafael Amado
Rafael Amado Executive Vice President, Head of R&D & Chief medical Officer @ Allogene Therapeutics
Executive Vice President, Head of R&D & Chief medical Officer
2019-09-01

susan-lundeen_image

Susan Lundeen
Susan Lundeen Chief People Officer @ Allogene Therapeutics
Chief People Officer
2022-05-02

Founder


arie-belldegrun_image

Arie Belldegrun

david-chang_image

David Chang

joshua-kazam_image

Joshua Kazam

Stock Details


Company's stock symbol is NASDAQ:ALLO

Investors List

franklin-templeton-investments_image

Franklin Templeton Investments

Franklin Templeton Investments investment in Convertible Note - Allogene Therapeutics

jennison-associates_image

Jennison Associates

Jennison Associates investment in Convertible Note - Allogene Therapeutics

venbio-select_image

venBio Select Advisor

venBio Select Advisor investment in Convertible Note - Allogene Therapeutics

fidelity-management-and-research-company_image

Fidelity Management and Research Company

Fidelity Management and Research Company investment in Convertible Note - Allogene Therapeutics

deerfield-management_image

Deerfield Capital Management

Deerfield Capital Management investment in Convertible Note - Allogene Therapeutics

surveyor-capital_image

Surveyor Capital

Surveyor Capital investment in Convertible Note - Allogene Therapeutics

perceptive-advisors_image

Perceptive Advisors

Perceptive Advisors investment in Convertible Note - Allogene Therapeutics

t-rowe-price_image

T. Rowe Price

T. Rowe Price investment in Convertible Note - Allogene Therapeutics

texas-pacific-group_image

TPG

TPG investment in Series A - Allogene Therapeutics

gilead-sciences_image

Gilead Sciences

Gilead Sciences investment in Series A - Allogene Therapeutics

Key Employee Changes

Date New article
2022-04-28 Allogene Therapeutics Appoints Susan Lundeen as Chief People Officer

Official Site Inspections

http://www.allogene.com Semrush global rank: 1.95 M Semrush visits lastest month: 11.07 K

  • Host name: allogene.therevoltgroup.com
  • IP address: 138.197.7.37
  • Location: Clifton United States
  • Latitude: 40.8364
  • Longitude: -74.1403
  • Metro Code: 501
  • Timezone: America/New_York
  • Postal: 07014

Loading ...

More informations about "Allogene Therapeutics" on Search Engine